Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017

Publisher Name :
Date: 14-Dec-2017
No. of pages: 116
Inquire Before Buying

This report studies Non-Insulin Therapies for Diabetes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- GSK

- Eli Lilly

- Sumitomo Dainippon Pharma

- Intarcia Therapeutics

- Servier

- Jiangsu Hansoh Pharmaceutical

- Novo Nordisk

- Emisphere

- Uni-Bio Science Group

- Takeda

- 3SBio

- Merck

- Dong-A Pharmaceutical

- Luye Pharma Group

- Eurofarma

- Geropharm

- Alkem Labs

- SatRx

- Pfizer

- Jiangsu Hengrui Medicine

By types, the market can be split into

- Alpha-glucosidase Inhibitors

- Amylin Agonists

- Biguanides

- Dipeptidyl Peptidase-4 (DPP4) Inhibitors

- Glinides / Meglitinides

- GLP-1 Analogs / GLP-1 Agonists

- Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

- Sulfonylureas

- Thiazolidinediones

- Others

By Application, the market can be split into

- Hospital Pharmacy

- Retail Pharmacies

- Online Pharmacy

- Others

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017

Table of Contents
Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017
1 Industry Overview of Non-Insulin Therapies for Diabetes
1.1 Definition and Specifications of Non-Insulin Therapies for Diabetes
1.1.1 Definition of Non-Insulin Therapies for Diabetes
1.1.2 Specifications of Non-Insulin Therapies for Diabetes
1.2 Classification of Non-Insulin Therapies for Diabetes
1.2.1 Alpha-glucosidase Inhibitors
1.2.2 Amylin Agonists
1.2.3 Biguanides
1.2.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
1.2.5 Glinides / Meglitinides
1.2.6 GLP-1 Analogs / GLP-1 Agonists
1.2.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
1.2.8 Sulfonylureas
1.2.9 Thiazolidinediones
1.2.10 Others
1.3 Applications of Non-Insulin Therapies for Diabetes
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacy
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Non-Insulin Therapies for Diabetes
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Non-Insulin Therapies for Diabetes
2.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
2.4 Industry Chain Structure of Non-Insulin Therapies for Diabetes
3 Technical Data and Manufacturing Plants Analysis of Non-Insulin Therapies for Diabetes
3.1 Capacity and Commercial Production Date of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
4 Global Non-Insulin Therapies for Diabetes Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Non-Insulin Therapies for Diabetes Capacity and Growth Rate Analysis
4.2.2 2016 Non-Insulin Therapies for Diabetes Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Non-Insulin Therapies for Diabetes Sales and Growth Rate Analysis
4.3.2 2016 Non-Insulin Therapies for Diabetes Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Non-Insulin Therapies for Diabetes Sales Price
4.4.2 2016 Non-Insulin Therapies for Diabetes Sales Price Analysis (Company Segment)
5 Non-Insulin Therapies for Diabetes Regional Market Analysis
5.1 North America Non-Insulin Therapies for Diabetes Market Analysis
5.1.1 North America Non-Insulin Therapies for Diabetes Market Overview
5.1.2 North America 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
5.1.4 North America 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.2 China Non-Insulin Therapies for Diabetes Market Analysis
5.2.1 China Non-Insulin Therapies for Diabetes Market Overview
5.2.2 China 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
5.2.4 China 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.3 Europe Non-Insulin Therapies for Diabetes Market Analysis
5.3.1 Europe Non-Insulin Therapies for Diabetes Market Overview
5.3.2 Europe 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
5.3.4 Europe 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.4 Southeast Asia Non-Insulin Therapies for Diabetes Market Analysis
5.4.1 Southeast Asia Non-Insulin Therapies for Diabetes Market Overview
5.4.2 Southeast Asia 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
5.4.4 Southeast Asia 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.5 Japan Non-Insulin Therapies for Diabetes Market Analysis
5.5.1 Japan Non-Insulin Therapies for Diabetes Market Overview
5.5.2 Japan 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
5.5.4 Japan 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.6 India Non-Insulin Therapies for Diabetes Market Analysis
5.6.1 India Non-Insulin Therapies for Diabetes Market Overview
5.6.2 India 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
5.6.4 India 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
6 Global 2012-2017E Non-Insulin Therapies for Diabetes Segment Market Analysis (by Type)
6.1 Global 2012-2017E Non-Insulin Therapies for Diabetes Sales by Type
6.2 Different Types of Non-Insulin Therapies for Diabetes Product Interview Price Analysis
6.3 Different Types of Non-Insulin Therapies for Diabetes Product Driving Factors Analysis
6.3.1 Alpha-glucosidase Inhibitors of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
6.3.2 Amylin Agonists of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
6.3.3 Biguanides of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
6.3.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
6.3.5 Glinides / Meglitinides of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
6.3.6 GLP-1 Analogs / GLP-1 Agonists of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
6.3.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
6.3.8 Sulfonylureas of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
6.3.9 Thiazolidinediones of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
6.3.10 Others of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
7 Global 2012-2017E Non-Insulin Therapies for Diabetes Segment Market Analysis (by Application)
7.1 Global 2012-2017E Non-Insulin Therapies for Diabetes Consumption by Application
7.2 Different Application of Non-Insulin Therapies for Diabetes Product Interview Price Analysis
7.3 Different Application of Non-Insulin Therapies for Diabetes Product Driving Factors Analysis
7.3.1 Hospital Pharmacy of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
7.3.2 Retail Pharmacies of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
7.3.3 Online Pharmacy of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
7.3.4 Others of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Non-Insulin Therapies for Diabetes
8.1 GSK
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 GSK 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 GSK 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.2 Eli Lilly
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Eli Lilly 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Eli Lilly 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.3 Sumitomo Dainippon Pharma
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Sumitomo Dainippon Pharma 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Sumitomo Dainippon Pharma 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.4 Intarcia Therapeutics
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Intarcia Therapeutics 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Intarcia Therapeutics 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.5 Servier
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Servier 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Servier 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.6 Jiangsu Hansoh Pharmaceutical
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Jiangsu Hansoh Pharmaceutical 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Jiangsu Hansoh Pharmaceutical 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.7 Novo Nordisk
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Novo Nordisk 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Novo Nordisk 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.8 Emisphere
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Emisphere 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Emisphere 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.9 Uni-Bio Science Group
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Uni-Bio Science Group 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Uni-Bio Science Group 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.10 Takeda
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Takeda 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Takeda 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.11 3SBio
8.12 Merck
8.13 Dong-A Pharmaceutical
8.14 Luye Pharma Group
8.15 Eurofarma
8.16 Geropharm
8.17 Alkem Labs
8.18 SatRx
8.19 Pfizer
8.20 Jiangsu Hengrui Medicine
9 Development Trend of Analysis of Non-Insulin Therapies for Diabetes Market
9.1 Global Non-Insulin Therapies for Diabetes Market Trend Analysis
9.1.1 Global 2017-2022 Non-Insulin Therapies for Diabetes Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Non-Insulin Therapies for Diabetes Sales Price Forecast
9.2 Non-Insulin Therapies for Diabetes Regional Market Trend
9.2.1 North America 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
9.2.2 China 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
9.2.3 Europe 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
9.2.5 Japan 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
9.2.6 India 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
9.3 Non-Insulin Therapies for Diabetes Market Trend (Product Type)
9.4 Non-Insulin Therapies for Diabetes Market Trend (Application)
10 Non-Insulin Therapies for Diabetes Marketing Type Analysis
10.1 Non-Insulin Therapies for Diabetes Regional Marketing Type Analysis
10.2 Non-Insulin Therapies for Diabetes International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Non-Insulin Therapies for Diabetes by Region
10.4 Non-Insulin Therapies for Diabetes Supply Chain Analysis
11 Consumers Analysis of Non-Insulin Therapies for Diabetes
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Non-Insulin Therapies for Diabetes
Table Product Specifications of Non-Insulin Therapies for Diabetes
Table Classification of Non-Insulin Therapies for Diabetes
Figure Global Production Market Share of Non-Insulin Therapies for Diabetes by Type in 2016
Figure Alpha-glucosidase Inhibitors Picture
Table Major Manufacturers of Alpha-glucosidase Inhibitors
Figure Amylin Agonists Picture
Table Major Manufacturers of Amylin Agonists
Figure Biguanides Picture
Table Major Manufacturers of Biguanides
Figure Dipeptidyl Peptidase-4 (DPP4) Inhibitors Picture
Table Major Manufacturers of Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Figure Glinides / Meglitinides Picture
Table Major Manufacturers of Glinides / Meglitinides
Figure GLP-1 Analogs / GLP-1 Agonists Picture
Table Major Manufacturers of GLP-1 Analogs / GLP-1 Agonists
Figure Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Picture
Table Major Manufacturers of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
Figure Sulfonylureas Picture
Table Major Manufacturers of Sulfonylureas
Figure Thiazolidinediones Picture
Table Major Manufacturers of Thiazolidinediones
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Non-Insulin Therapies for Diabetes
Figure Global Consumption Volume Market Share of Non-Insulin Therapies for Diabetes by Application in 2016
Figure Hospital Pharmacy Examples
Table Major Consumers of Hospital Pharmacy
Figure Retail Pharmacies Examples
Table Major Consumers of Retail Pharmacies
Figure Online Pharmacy Examples
Table Major Consumers of Online Pharmacy
Figure Others Examples
Table Major Consumers of Others
Figure Market Share of Non-Insulin Therapies for Diabetes by Regions
Figure North America Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure China Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure Europe Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure Japan Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure India Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Table Non-Insulin Therapies for Diabetes Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Non-Insulin Therapies for Diabetes in 2016
Figure Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
Figure Industry Chain Structure of Non-Insulin Therapies for Diabetes
Table Capacity and Commercial Production Date of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Non-Insulin Therapies for Diabetes 2012-2017
Figure Global 2012-2017E Non-Insulin Therapies for Diabetes Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Non-Insulin Therapies for Diabetes Market Size (Value) and Growth Rate
Table 2012-2017E Global Non-Insulin Therapies for Diabetes Capacity and Growth Rate
Table 2016 Global Non-Insulin Therapies for Diabetes Capacity () List (Company Segment)
Table 2012-2017E Global Non-Insulin Therapies for Diabetes Sales () and Growth Rate
Table 2016 Global Non-Insulin Therapies for Diabetes Sales () List (Company Segment)
Table 2012-2017E Global Non-Insulin Therapies for Diabetes Sales Price ()
Table 2016 Global Non-Insulin Therapies for Diabetes Sales Price () List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure North America 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure North America 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure China 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure China 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure Europe 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure Europe 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure Southeast Asia 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure Southeast Asia 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure Japan 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure Japan 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure India 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure India 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Table Global 2012-2017E Non-Insulin Therapies for Diabetes Sales () by Type
Table Different Types Non-Insulin Therapies for Diabetes Product Interview Price
Table Global 2012-2017E Non-Insulin Therapies for Diabetes Sales () by Application
Table Different Application Non-Insulin Therapies for Diabetes Product Interview Price
Table GSK Information List
Table Product A Overview
Table Product B Overview
Table 2016 GSK Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 GSK Non-Insulin Therapies for Diabetes Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Eli Lilly Non-Insulin Therapies for Diabetes Business Region Distribution
Table Sumitomo Dainippon Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2015 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Business Region Distribution
Table Intarcia Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Business Region Distribution
Table Servier Information List
Table Product A Overview
Table Product B Overview
Table 2016 Servier Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Servier Non-Insulin Therapies for Diabetes Business Region Distribution
Table Jiangsu Hansoh Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Business Region Distribution
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Novo Nordisk Non-Insulin Therapies for Diabetes Business Region Distribution
Table Emisphere Information List
Table Product A Overview
Table Product B Overview
Table 2016 Emisphere Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Emisphere Non-Insulin Therapies for Diabetes Business Region Distribution
Table Uni-Bio Science Group Information List
Table Product A Overview
Table Product B Overview
Table 2016 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Business Region Distribution
Table Takeda Information List
Table Product A Overview
Table Product B Overview
Table 2016 Takeda Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Takeda Non-Insulin Therapies for Diabetes Business Region Distribution
Table 3SBio Information List
Table Merck Information List
Table Dong-A Pharmaceutical Information List
Table Luye Pharma Group Information List
Table Eurofarma Information List
Table Geropharm Information List
Table Alkem Labs Information List
Table SatRx Information List
Table Pfizer Information List
Table Jiangsu Hengrui Medicine Information List
Figure Global 2017-2022 Non-Insulin Therapies for Diabetes Market Size () and Growth Rate Forecast
Figure Global 2017-2022 Non-Insulin Therapies for Diabetes Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Non-Insulin Therapies for Diabetes Sales Price () Forecast
Figure North America 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure China 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure Europe 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure Japan 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure India 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Table Global Sales Volume () of Non-Insulin Therapies for Diabetes by Type 2017-2022
Table Global Consumption Volume () of Non-Insulin Therapies for Diabetes by Application 2017-2022
Table Traders or Distributors with Contact Information of Non-Insulin Therapies for Diabetes by Region
  • Global Myelodysplastic Syndrome Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 128
    Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood cells.[2] Early on there are typically no symptoms.Later symptoms may include feeling tired, shortness of breath, easy bleeding, or frequent infections.[2] Some types may develop into acute myeloid leukemia. The presence of diagnostic tools is the key driver for the growth of this market. Diagnosis techniques like blood count, peri......
  • Global Myasthenia Gravis Drugs Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 120
    Acetylcholine esterase (AChE) inhibitors are considered to be the basic treatment of myasthenia gravis (MG). Edrophonium is primarily used as a diagnostic tool owing to its short half-life. Pyridostigmine is used for long-term maintenance. The market is witnessing the rapid development of novel drugs such as monoclonal antibodies, which is one of the primary factors driving this market's growth prospects. Most drug manufacturers are increasingly focussing on the development of monoclonal ......
  • Global MRSA Drugs Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 122
    Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. The infection causes skin and tissue infection, and is transmitted by direct skin-to-skin contact......
  • Global Fibrin Sealants Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 125
    Fibrin sealant, a two-component substance consisting of thrombin and fibrinogen, is used as a hemostatic or adhesive in various surgical solutions. In clinical practice, a fibrin sealant consists of a concentrated solution of fibrinogen and Factor XIII, which combine with a solution of calcium and thrombin to form a coagulum that stimulates clotting. Beriplast P and TISSEEL are some of the commercially available fibrin sealants. The Americas accounted for 48% of the market share during th......
  • Global Female Contraceptive Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 110
    Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology. Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market. The Americas will be the major revenue contributor to the contraceptive pills market thr......
  • Global Female Condoms Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 114
    A female condom is a birth control device that acts as a barrier to prevent sexual fluids from entering the vagina during intercourse. It protects against pregnancy and sexually transmitted infections (STIs). The online stores will be the fastest-growing segment and will continue to maintain its lead in the global market. Much of the segment's growth is due to its higher penetration rate and adoptability. Female condoms are easily accessible online and allow for useful comparison in terms......
  • Global Excipients Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 111
    Excipients are inert substances that are generally used to manufacture different forms of drugs and are present in the finished products. Excipients help in providing long-term stability and make solid formulations bulkier. They also improve the functionality of drugs and make them safer. Based on functionality, the pharmaceutical excipients market is segmented into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disint......
  • Global Consumer Healthcare Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 127
    Consumer healthcare products include trusted brands of multivitamins and iron supplements, in addition to products for allergies, personal hygiene, sleep support, alertness and cold and flu. Consumer health products do not require a written prescription from healthcare professionals but can be purchased directly from a pharmacy store. The global Consumer Healthcare market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx%......
  • Global Intravenous (IV) Ibuprofen Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 114
    Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The global Intravenous (IV) Ibuprofen market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous (IV) Ibuprofen ma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs